Pharmacies as potential providers of harm reduction services: A preliminary online survey

@article{James2018PharmaciesAP,
  title={Pharmacies as potential providers of harm reduction services: A preliminary online survey},
  author={Edward James and Thomas L Robertshaw and Andrew D. Westwell and Andrew P. Smith},
  journal={Drug Science, Policy and Law},
  year={2018},
  volume={4}
}
Background Recreational drug use is a major cause of disease, injury, physical and mental impairment and death in developed countries such as the United Kingdom and the United States. Alcohol, tobacco, cannabis, 3,4-methylenedioxymethamphetamine (MDMA) and psilocybe mushrooms are recreational drugs with capacity to cause harm. Cannabis, MDMA and psilocybin have reported therapeutic applications. Objectives The primary purpose of this study was to determine which of the three types of vendor… 

Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs

A majority of the male participants concluded that being legally permitted to consume alcohol, tobacco, cannabis and Psilocybe mushrooms is a human right in contrast to the majority of female participants who solely considered alcohol consumption to be a humanright.

Online survey into developing a model for a legal cannabis market in the United Kingdom

A model for a legal cannabis market in the UK building upon the results of a preceding study in which a UK population sample determined that pharmacies are the most suitable primary legal vendor of cannabis as opposed to regulated shops or the black market is developed.

References

SHOWING 1-10 OF 111 REFERENCES

Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey

A rare sample of 93 drug users with personal experience with 11 different illicit drugs that are widely used in the UK are identified, providing a useful insight into the opinions of experienced drug users on a subject about which they have a rare and intimate knowledge.

Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland

The harm rankings of 19 commonly used substances did not match the A, B, C classification under the Misuse of Drugs Act, and the legality of a substance of misuse is not correlated with its perceived harm.

Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population

Whether the legal classification of drugs in the Netherlands corresponds with the ranking of the drugs according to their science-based ranking of harm based on the scientific state of the art is evaluated.

Drug harms in the UK: a multicriteria decision analysis

The medicinal use of cannabis in the UK: results of a nationwide survey

The results of a self‐administered questionnaire study conducted in the United Kingdom between 1998 and 2002 point to the need for clinical studies of cannabis and cannabinoids with standardised and quality‐controlled products.

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

The findings of this study support recent calls for a systematic investigation of the therapeutic potential of the classic hallucinogens and highlight the scope for empirical investigations of spiritual and psychodynamic phenomena.

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?

It is argued that increased policing of cannabis use under the current drug classification system will lead to increased criminalization of young people, but is unlikely to significantly reduce the rates of schizophrenia and psychosis.

Substance abuse and violence: A review of the literature

Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics

Pain, insomnia, and anxiety were the most common conditions for which evaluating physicians recommended medical marijuana, and shifts in the medical marijuana patient population over time, the need for further research, and the issue of diversion are discussed.
...